PHARMACEUTICAL COMPOSITION COMPRISING REMOGLIFLOZIN OR SALT OR ESTER THEREOF AND TENELIGLIPTIN OR SALT THEREOF

摘要

The invention relates to a fixed dose combination of remogliflozin or pharmaceutically acceptable salt or ester thereof and DPP-IV inhibitor or pharmaceutically acceptable salt thereof. In particular, a fixed dose combination of remogliflozin or pharmaceutically acceptable salt or ester thereof and teneligliptin or pharmaceutically acceptable salt thereof. This fixed dosed combination is suitable for twice a day administration. More preferably, there is provided a pharmaceutical composition comprising a fixed dose combination of remogliflozin etabonate and teneligliptin hydrobromide or oxalate salt.